|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross loss | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Operations | |||||
| Sales and marketing | |||||
| Impairment of long-lived assets | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Interest expense, net | |||||
| Interest income (expense), net | |||||
| Interest income | |||||
| Interest expense | |||||
| Realized gain on foreign currency translation | |||||
| Realized gain on investments | |||||
| Change in fair value of derivative liability | |||||
| Change in fair value of simple agreements for future equity | |||||
| Total other income (expense), net | |||||
| Other income | |||||
| Net loss before income taxes | |||||
| Benefit from income taxes | |||||
| Net loss | |||||
| Other comprehensive income, net of tax: | |||||
| Unrealized gain on investments | |||||
| Other comprehensive income, before tax | |||||
| Income tax expense related to items of other comprehensive income | |||||
| Other comprehensive income, net of tax | |||||
| Comprehensive loss | |||||
| Weighted average common shares outstanding - basic (in shares) | |||||
| Weighted average common shares outstanding - diluted (in shares) | |||||
| Net loss per common share - basic (in dollars per share) | |||||
| Net loss per common share - diluted (in dollars per share) | |||||
Loading...